MolNFT v1 · #116270 · protein
Development of a therapeutic monoclonal antibody targeting secreted AP2 to treat type 2 diabetes.
5D8J: “Development of a therapeutic monoclonal antibody targeting secreted AP2 to treat type 2 diabetes.”. X-ray diffraction. MolNFT v1 #116270 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5D8J
- Type
- protein
- Length
- 563 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P04117
Structure
x-ray diffraction · 3 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 133 | — | P04117 |
| H | — | protein | 216 | — | — |
| L | — | protein | 214 | — | — |
Compared structures
- 5D8J · Development of a therapeutic monoclonal antibody targeting secreted aP2 to treat type 2… · the same entry in another collection · chain H against H, TM-score 1.00
- P04117 · AlphaFold monomer V2.0 prediction for fatty acid-binding protein, adipocyte (P04117) · a predicted model of the same protein · chain A against A, TM-score 0.96
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P04117
- Elsewhere: RCSB PDB 5D8J · PDBe 5D8J · UniProt P04117
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.